![](https://moleculight.com/wp-content/uploads/2021/02/Publication-Categories2_Treatment-Planning-1000-x-510.jpg)
![](https://moleculight.com/wp-content/uploads/2021/01/19_Raizman-1_Publication-List-450-x-265.jpg)
9/10 wound care patients more appropriately triaged with fluorescence information
60% of these 9 patients would have been undertreated while 30% of patients were being overtreated
$1552 Single patient cost savings (USD) due to fluorescence evidence-based treatment plan changes